CCEL

Cryo-Cell International, Inc. (CCEL) ESG Analysis Analysis (2026)

Invetso Score: 5.5/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.8 (Moderate)

CCEL appears less exposed to direct environmental intensity than industrial peers, but the provided metrics do not evidence superior emissions, energy, or waste management practices.

Low R&D intensity relative to revenue suggests limited environmental innovation capacity versus peers that are investing more in process efficiency and lower-impact service delivery.

The absence of disclosed environmental operating metrics in the supplied data limits evidence of proactive environmental leadership, leaving positioning broadly in line with smaller service peers.

Environmental risk is likely more indirect than operational, which reduces structural exposure versus heavy-emitting peers but does not establish a clear ESG advantage.

Social

Score:

CCEL’s service-oriented model likely carries lower workforce and community externalities than asset-heavy peers, but the supplied data do not show differentiated social programs or outcomes.

Stock-based compensation at under 1% of revenue suggests restrained dilution, yet it does not by itself demonstrate stronger employee alignment or retention versus peers.

No customer safety, labor, or human-capital disclosure is provided here, so social positioning cannot be assessed as stronger than peers on evidence alone.

Relative to larger healthcare or consumer-service peers, CCEL appears operationally simpler, but the available metrics do not confirm superior social governance or stakeholder management.

Governance

Score:

Very high net debt to EBITDA indicates weaker balance-sheet discipline than many peers, which can heighten governance scrutiny around capital allocation and oversight.

Negative debt-to-equity likely reflects equity deficits or accounting distortion, but either way it signals a less resilient capital structure than better-capitalized peers.

Low stock-based compensation is a modest governance positive because it limits shareholder dilution, though it is insufficient to offset leverage-related concerns.

The provided data contain no board, audit, or disclosure-quality indicators, so governance assessment remains constrained and only moderately positioned versus peers.

Overall Score

Score:

CCEL’s ESG positioning is broadly average to slightly below peers, with limited environmental and social evidence and a comparatively weaker capital-structure profile.

Score Driver: High Leverage And Limited ESG Disclosure Visibility Are The Main Factors Preventing A Stronger Relative ESG Assessment.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Cryo-Cell International, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →